Royalty Pharma plc Profile Avatar - Palmy Investing

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]

Balance Sheet

7 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2017 2018 2019 2020 2021 2022 2023
Assets
- - 11,370.00 12,449.00 21,097.00 17,515.00 16,813.00 16,381.00
Current
- - 2,608.00 832.00 2,696.00 2,878.00 2,554.00 1,274.00
Non Current
- - 8,761.00 11,617.00 13,323.00 14,637.00 14,258.00 15,107.00
Liabilities
- - 6,818.00 6,308.00 6,124.00 7,267.00 7,288.00 6,297.00
Current
- - 580.00 333.00 307.00 171.00 1,166.00 161.00
Non Current
- - 6,237.00 5,975.00 5,816.00 7,096.00 6,121.00 6,136.00
Equity
- - 4,552.00 6,141.00 14,973.00 10,248.00 9,525.00 10,084.00
Stockholders' Equity
- - 4,488.00 6,105.00 9,896.00 5,776.00 5,628.00 6,526.00
Retained Earnings
- - 1,215.00 2,825.00 1,920.00 2,255.00 1,964.00 2,517.00
Common Stock
- - 3,282.00 3,282.00 - - - - - - - -
Preferred Stock
- - - - - - - - - - - - - -
Profit
1,210.00 1,377.00 2,348.00 495.00 478.00 42.00 1,134.00
Dividends
-735.00 -814.00 -739.00 -397.00 -285.00 -333.00 -358.00
Minority Interest
- - 63.00 35.00 5,077.00 4,471.00 3,897.00 3,557.00
Other Stockholders' Equity
- - - - -4.00 7,940.00 3,504.00 3,663.00 4,008.00
Loss Other Compr. Income
- - -10.00 2.00 34.00 16.00 - - - -
End of RPRX's Analysis
CIK: 1802768 CUSIP: G7709Q104 ISIN: GB00BMVP7Y09 LEI: - UEI: -
Secondary Listings
RPRX has no secondary listings inside our databases.